Subject no | Sex | Age (y) | Height (cm) | Weight (kg) | Medication | FVC (l) | FVC (% pred) | FEV1(l) | FEV1 (% pred) | MMF (l/s) | MMF (% pred) | PEF (l/s) | PEF (% pred) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Training group | |||||||||||||
1 | M | 10 | 126.5 | 25.4 | T,B,C,β | 2.06 | (105) | 1.28 | (75) | 0.87 | (40) | 3.31 | (96) |
2 | F | 10 | 126.0 | 25.0 | T | 1.63 | (89) | 1.33 | (83) | 1.29 | (63) | 3.67 | (125) |
3 | M | 10 | 137.0 | 34.0 | T,B,β | 2.44 | (101) | 1.88 | (90) | 1.66 | (66) | 4.34 | (103) |
4 | M | 9 | 129.5 | 28.0 | T,B,C,β | 1.99 | (99) | 1.34 | (77) | 0.96 | (44) | 3.03 | (86) |
5 | M | 12 | 159.0 | 47.0 | T,C | 1.93 | (87) | 1.57 | (81) | 1.45 | (61) | 5.66 | (146) |
6 | M | 11 | 133.5 | 28.8 | T,B,C,β | 2.28 | (89) | 1.76 | (79) | 1.46 | (56) | 5.76 | (129) |
7 | M | 11 | 142.0 | 38.0 | — | 3.37 | (99) | 2.41 | (82) | 1.92 | (59) | 5.34 | (91) |
8 | M | 11 | 124.0 | 21.2 | T | 2.01 | (115) | 1.59 | (105) | 1.47 | (74) | 4.17 | (136) |
Mean | 10.5 | 134.7 | 30.9 | 2.21 | (98.0) | 1.65 | (84.0) | 1.39 | (57.8) | 4.41 | (114.0) | ||
SD | 0.9 | 11.6 | 8.4 | 0.52 | (9.5) | 0.38 | (9.6) | 0.35 | (11.2) | 1.07 | (22.7) | ||
Control group | |||||||||||||
1 | M | 10 | 146.0 | 37.0 | — | 2.28 | (71) | 1.8 | (65) | 1.58 | (51) | 4.3 | (78) |
2 | M | 11 | 133.0 | 26.2 | T,B,β | 1.87 | (85) | 1.26 | (66) | 0.84 | (36) | 3.18 | (83) |
3 | M | 10 | 137.0 | 32.8 | T,B,C,β | 1.66 | (71) | 1.15 | (57) | 0.85 | (35) | 2.84 | (69) |
4 | M | 8 | 119.0 | 26.7 | T,B,C,β | 1.77 | (123) | 1.54 | (124) | 1.62 | (92) | 3.34 | (131) |
5 | M | 9 | 133.0 | 28.0 | T | 1.87 | (87) | 1.34 | (72) | 1.09 | (47) | 2.94 | (78) |
6 | M | 11 | 137.0 | 24.0 | T,β | 1.66 | (89) | 1.49 | (92) | 0.92 | (44) | 3.04 | (93) |
7 | M | 10 | 133.5 | 27.0 | — | 2.15 | (96) | 1.71 | (89) | 1.58 | (67) | 3.71 | (96) |
8 | F | 10 | 129.0 | 25.0 | B | 1.78 | (97) | 1.63 | (101) | 2.21 | (108) | 3.56 | (121) |
Mean | 9.9 | 133.4 | 28.3 | 1.88 | (89.8) | 1.49 | (83.2) | 1.34 | (60.0) | 3.36 | (93.6) | ||
SD | 1.0 | 7.7 | 4.4 | 0.22 | (16.6) | 0.23 | (22.4) | 0.49 | (26.9) | 0.48 | (21.9) | ||
Difference between groups | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
FVC = forced vital capacity; FEV1 = forced expiratory volume in one second; MMF = maximal mid-expiratory flow rate; PEF = peak expiratory flow rate; NS = not significant; T = theophylline; B = beclomethasone dipropionate; C = disodium cromoglycate; β = β2 agonist.